Skip to main content
Figure 4 | BMC Musculoskeletal Disorders

Figure 4

From: Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-β2

Figure 4

Neutralizing anti-TGF-β 2 antibodies block TGF-β 2 stimulated FPCL contraction. (A) Control and (B) disease FPCL cultures (± 1 ng/ml TGF-β2) were treated with the indicated concentrations of neutralizing anti-TGF-β2 antibodies. FPCL contraction was analyzed and plotted as the mean surface area ± SDM for quadruplicate cultures per treatment.

Back to article page